School of Medicine
Showing 291-300 of 302 Results
-
Kelly H. Yoo, MD, PhD
Postdoctoral Scholar, Neurosurgery
BioDr. Kelly H. Yoo is a postdoctoral scholar in the Department of Neurosurgery at Stanford University, specializing in innovative therapeutic strategies for neurosurgical pathologies. She earned her M.D. and Ph.D. from Heidelberg University School of Medicine, where her doctoral research focused on combining CAR T cell immunotherapy with ibrutinib and a reactive oxygen species accelerator, PipFcB, for hematologic malignancies. Graduating in the top 1% of her class, Dr. Yoo was recruited early for her residency in neurosurgery, where she honed her expertise in the interdisciplinary application of combinatorial treatment strategies.
Building on the knowledge she gained during her doctoral training, she worked to integrate CAR T cell therapy with bevacizumab, temozolomide chemotherapy, and radiation therapy for neurosurgical patients with primary and recurrent glioblastoma. As part of the clinician-scientist track, Dr. Yoo has completed several certifications, including Good Clinical Practice, the Principal Investigators Course, the Clinical Trial Investigators Course, and the Munich Investigators Course. These experiences have equipped her to design translational research that effectively bridges the gap between bench and bedside.
Recognized as a top 0.1% resident by the Baden-Württemberg Medical Association for her exceptional clinical and research performance, Dr. Yoo joined the Department of Neurosurgery at Stanford University to advance her career through a postdoctoral fellowship. -
Moss Zhao
Instructor, Neurosurgery
BioDr. Moss Zhao is an Instructor at Department of Neurosurgery, Stanford University. He develops cutting-edge and clinically viable imaging technologies to improve the diagnosis and treatment of cerebrovascular diseases across the lifespan. His specific areas of expertise include physiological modeling, arterial spin labeling, Bayesian inference, PET/MRI, and artificial intelligence. His scientific contributions could significantly improve the early detection of strokes and dementia as well as enrich the knowledge of brain development in the first two decades of life.
Dr. Zhao received his DPhil at St Cross College of University of Oxford under the supervision of Prof. Michael Chappell. As an alumni mentor, he supports the career development of students of his alma mater. Since 2016, he has presented his work to more than 3000 delegates at international conferences and held leadership positions in professional societies. His research and teaching are supported by the American Heart Association, the National Institutes of Health, and the European Cooperation in Science and Technology. -
Quan Zhou
Instructor, Neurosurgery
Affiliate, NeurosurgeryCurrent Research and Scholarly InterestsCurrent Research Focus: molecular targeted theranostic imaging of brain tumor and enhanced drug delivery
Areas of Insterests: molecular imaging, theranostics, fluorescence-guided surgery, brain tumor, drug delivery
Dr. Zhou has made substantial contributions to the growing biomedical research field of Molecular Imaging. Molecular imaging emerged in the mid twentieth century as a highly specialized discipline at the intersection of molecular biology and in vivo imaging, focusing on imaging molecules of medical interest within intact living subjects. Dr. Zhou’s research addresses some of the nation’s most pressing issues related to the development of effective approaches for accurate detection of human diseases and improving their treatment outcome. Her innovations in molecular imaging technology enables the visualization, characterization, and quantification of biologic processes taking place at the cellular and subcellular levels. The multiple and numerous potentialities of Quan’s work are applicable to the diagnosis of diseases such as cancer, neurological and cardiovascular diseases. Her strong education background in biological sciences and biomedical engineering followed by postdoctoral training in translational and clinical research have helped her develop multiple disease-specific molecular probes and imaging strategies for early cancer diagnosis, image-guided surgery, therapeutic delivery prediction and at-risk cardiovascular plaque detection. Her research also contributes to improving the treatment of these disorders by testing and optimizing the execution of new interventions. Her work is expected to have a major economic impact due to earlier disease detection and personalized therapy.
Dr. Zhou’s research has led to emergence of novel solutions and opportunities, in particular, for molecular imaging of cancer and other diseases, for discovering, leveraging and integration of cancer biomarker and tumor microenvironment information, and for novel approaches to acquire real-time high-resolution contrast enhanced visualization of tumor margin and optimization based on imaging depth, quality and speed. Dr. Zhou has been able to formulate the involved clinical and biological problems into biomedical engineering frameworks and find ways to exploit a variety of modern techniques and approaches from photoacoustic imaging, fluorescence-guided surgery, micro-electromechanical systems and therapeutic delivery strategies in developing elegant and effective solutions. Her work in the Neurosurgery Department and Molecular Imaging Program at Stanford involves research related to developing tumor-specific molecular probes, advanced imaging methods and therapeutic delivery systems for adult and pediatric patients with malignant brain cancers to improve margin detection, enhance resection accuracy, and improve treatment outcome.
